Parkman Healthcare Partners’s SeaSpine Holdings Corporation Common Stock SPNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-225,000
Closed -$4.62M 88
2021
Q2
$4.62M Buy
225,000
+34,253
+18% +$704K 1.01% 38
2021
Q1
$3.32M Sell
190,747
-184,198
-49% -$3.3M 0.77% 41
2020
Q4
$6.54M Buy
374,945
+6,132
+2% +$93.4K 1.68% 24
2020
Q3
$5.27M Buy
368,813
+123,028
+50% +$1.49M 1.4% 31
2020
Q2
$2.57M Hold
245,785
0.72% 47
2020
Q1
$2.01M Buy
245,785
+133,345
+119% +$1.76M 0.93% 35
2019
Q4
$1.35M Buy
+112,440
New +$1.37M 0.39% 59

Other funds holding SPNE

Parkman Healthcare Partners's SPNE Position: Q3 2021 in Review

Parkman Healthcare Partners sold out of SeaSpine Holdings Corporation Common Stock (SPNE) in Q3 2021, closing a stake of 225,000 shares — an estimated $4.62M sold.

Parkman Healthcare Partners first reported a position in SPNE in Q4 2019 and held it in 7 quarters. The position peaked at $6.54M in Q4 2020. 93 funds tracked by Wall St. Rank hold SPNE as of Q3 2021.

  • Parkman Healthcare Partners reported no remaining SeaSpine Holdings Corporation Common Stock position as of Q3 2021 after selling out during the quarter.
  • Parkman Healthcare Partners sold 225,000 SeaSpine Holdings Corporation Common Stock shares in Q3 2021, an estimated $4.62M.
  • Parkman Healthcare Partners first reported a position in SeaSpine Holdings Corporation Common Stock in Q4 2019 and held it in 7 quarters.
  • Parkman Healthcare Partners's SeaSpine Holdings Corporation Common Stock position peaked at $6.54M in Q4 2020.
  • 93 funds tracked by Wall St. Rank held SeaSpine Holdings Corporation Common Stock as of Q3 2021.

Based on Parkman Healthcare Partners's 13F filing for Q3 2021, filed 12 Nov 2021.